Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery

他のバージョン（1件）を表示する

書誌詳細
主要な著者:	Pringle, I, Davies, L, Hyde, S, Gill, D
フォーマット:	Conference item
出版事項:	Elsevier 2018

類似資料

Expression profile of optimised SIV vector in the mouse lung at early timepoints post-delivery
著者:: Pringle, I, 等
出版事項: (2018)

Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
著者:: Hyde, S, 等
出版事項: (2015)

A method for assessing the distribution of eGFP expressing cells in the mouse lung following lentiviral vector transduction
著者:: Munday, R, 等
出版事項: (2018)

Optimising non-viral gene delivery in a tumour spheroid model.
著者:: Mellor, H, 等
出版事項: (2006)

Influence of CpG-dinucleotide motifs on the duration of gene expression from plasmid, vectors after in vivo lung delivery
著者:: Gill, DR, 等
出版事項: (2007)

Topical delivery of NF-kb decoy related oligodeoxynucleotides reduces pro-inflammatory cytokine response associated with cationic lipid: pDNA vector delivery to murine lungs
著者:: Varathalingam, 等
出版事項: (2004)

Rapid determination of rSIV.F/HN lentiviral vector titre
著者:: Conway, CC, 等
出版事項: (2020)

Large-scale, high-throughput production of rSIV.F/HN vectors
著者:: Viegas, MFA, 等
出版事項: (2020)

OPTIMISATION OF MOLECULAR ASSAYS FOR CLINICAL TRIAL OF GL67A/PDNA DELIVERY TO NOSE AND LUNG OF CF PATIENTS
著者:: Sumner-Jones, S, 等
出版事項: (2009)

Safety profile of dextran-spermine gene delivery vector in mouse lungs
著者:: Yeo, Wendy Wai Yeng, 等
出版事項: (2014)

1-year mortality in lung cancer in France according to key timepoints of care pathways
著者:: Axelle Rivière, 等
出版事項: (2022-11-01)

The development of gene therapy for diseases of the lung.
著者:: Gill, DR, 等
出版事項: (2004)

Autoimmune encephalitis: Early and late findings on serial MR imaging and correlation to treatment timepoints
著者:: Mahmoud Abunada, 等
出版事項: (2024-06-01)

Progress and prospects: the design and production of plasmid vectors.
著者:: Gill, DR, 等
出版事項: (2009)

Incremental intervention effects in studies with dropout and many timepoints#
著者:: Kim Kwangho, 等
出版事項: (2021-12-01)

Identification and Characterization of Metastasis‐Initiating Cells in ESCC in a Multi‐Timepoint Pulmonary Metastasis Mouse Model
著者:: Ching Ngar Wong, 等
出版事項: (2024-08-01)

Improving the quantification of rSIV.F/HN vectors for cystic fibrosis gene therapy using droplet digital PCR
著者:: Gamlen, T, 等
出版事項: (2020)

Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.
著者:: Pringle, I, 等
出版事項: (2009)

Gene co-expression network analysis provides novel insights into myostatin regulation at three different mouse developmental timepoints.
著者:: Xuerong Yang, 等
出版事項: (2015-01-01)

Stability of Blood DNA Methylation Across Two Timepoints in Three Cohorts
著者:: Mikołaj Danielewski, 等
出版事項: (2024-11-01)

Key correlates of exclusive breastfeeding at three timepoints: Evidence from Ethiopia
著者:: Seblewongel Yigletu, 等
出版事項: (2022-12-01)

Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
著者:: Archana V. Boopathy, 等
出版事項: (2023-11-01)

Cumulative CFTR expression following repeated aerosol delivery of non-viral pGM169/GL67A formulation to mouse lung
著者:: Alton, E, 等
出版事項: (2012)

Immunobiological Correlates of SIV Vaccine Vectors and Macaque Tropism
著者:: Joseph Antony
出版事項: (2019-12-01)

Multi-Timepoint Metabolic Fingerprinting of a Post-Episode Period of Hypoglycemia and Ketoacidosis Among Children With Type 1 Diabetes
著者:: Beata Małachowska, 等
出版事項: (2022-06-01)

AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
著者:: Paolo Molinari, 等
出版事項: (2021-12-01)

Neuropsychological predictors of conversion from mild cognitive impairment to dementia at different timepoints
著者:: Davide Quaranta, 等
出版事項: (2023-09-01)

Optimisation of DNA vector activity and delivery for improved vaccination
著者:: Hettinga, JK
出版事項: (2022)

Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector
著者:: Sergijenko, A, 等
出版事項: (2021)

ENaC knockdown in the mouse lung using RNAi
著者:: Hyde, S, 等
出版事項: (2007)

Detection of plasmid DNA vectors following gene transfer to the murine airways.
著者:: Pringle, I, 等
出版事項: (2005)

CASi: A framework for cross-timepoint analysis of single-cell RNA sequencing data
著者:: Yizhuo Wang, 等
出版事項: (2024-05-01)

Evaluation of levocetirizine in beagle dog and cynomolgus monkey telemetry assays: Defining the no QTc effect profile by timepoint and concentration‐QTc analysis
著者:: Michael J. Engwall, 等
出版事項: (2023-03-01)

Optomising non-viral gene delivery in a tumuor spheroid model
著者:: Mellor, H, 等
出版事項: (2006)

Aerosol delivery of DNA/liposomes to the lung for cystic fibrosis gene therapy.
著者:: Davies, L, 等
出版事項: (2014)

431. Lung antibody factory for passive immunisation against influenza
著者:: Tan, T, 等
出版事項: (2016)

Towards gene therapy for cystic fibrosis: Biodistribution of GL67A/pGM169 DNA and mRNA following aerosol delivery to the mouse lung
著者:: Pringle, I, 等
出版事項: (2008)

Plasmid Inhalation: Delivery to the Airways
著者:: Davies, L, 等
出版事項: (2006)

Lack of repeat transduction by recombinant adeno-associated virus type 5/5 vectors in the mouse airway.
著者:: Sumner-Jones, S, 等
出版事項: (2007)

Early ART reduces viral seeding and innate immunity in liver and lungs of SIV-infected macaques
著者:: Julien A. Clain, 等
出版事項: (2023-07-01)